Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
RS Minova AB
AB
Active
Org 5595064345
Lancashirevägen 5, 735 60
Ramnäs
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2024 · 1 year old
1-4 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
RS Minova AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1M
1M
1M
0M
0M
2025: 1M
1M
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
Revenue
804
Staff expenses
−336
EBITDA
8
Depreciation & amort.
—
EBIT
8
Net financials
−0
Profit before tax
8
Tax
−2
Net profit
6
Balance sheet
SEK thousands
Item
2025
Total assets
69
Equity
31
Long-term debt
—
Short-term debt
38
Total debt
38
Financial ratios
5-year trend
EBITDA margin
1,0 %
This company
15,8 %
Market median
This company
Market median
94% below market
2025
2025
Equity ratio
44,7 %
This company
38,2 %
Market median
This company
Market median
17% above market
2025
2025
Return on equity
18,8 %
This company
18,4 %
Market median
This company
Market median
2% above market
2025
2025
Net profit margin
0,7 %
This company
8,1 %
Market median
This company
Market median
91% below market
2025
2025
Asset turnover
11,66×
This company
1,12×
Market median
This company
Market median
941% above market
2025
2025
Debt / equity
1,24×
This company
0,62×
Market median
This company
Market median
100% above market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-11-21 – 2025-12-31
View
PDF
More on RS Minova AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
